Intellia Therapeutics Announces Closing of Initial Public Offering
The net proceeds of the offering to Intellia were approximately
A registration statement relating to these securities was declared effective by the
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Jennifer Mound SmoterChief External Affairs & Communications Officer +1 224-804-4462 firstname.lastname@example.org John Graziano Trout Group646- 378-2942 Chad Rubin Trout Group646 378-2947